Surgery Partners (SGRY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $14.61, -1.08% vs the prior close of $14.77.
- Volume 966.78K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SGRY dips 1.1% to $14.61. Closed at $14.61, -1.08% vs the prior close of $14.77. Day range $14.51–$14.89, opened at $14.86.
SGRY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SGRY dips 1.1% to $14.61
- Closed at $14.61, -1.08% vs the prior close of $14.77. Day range $14.51–$14.89, opened at $14.86.
- Volume was 966.78K shares, 0.4x its 50-day average of 2.32M — lighter than usual.
- Price is +2.7% vs its 50-day average ($14.22) and +1.1% vs its 200-day average ($14.44).
- 52-week range $11.41–$23.44; today's close sits at 27% of that range, 37.7% below the 52-week high.
Oct 15, 2026 — SGRY dips 0.4% to $14.77
- Closed at $14.77, -0.40% vs the prior close of $14.83. Day range $14.61–$15.34, opened at $15.05.
- Volume was 2.37M shares, 1.0x its 50-day average of 2.30M.
- Price is +3.8% vs its 50-day average ($14.23) and +2.2% vs its 200-day average ($14.45).
- 52-week range $11.41–$23.44; today's close sits at 28% of that range, 37.0% below the 52-week high.
Oct 14, 2026 — SGRY rises 1.9% to $14.83, 4 up days in a row
- Closed at $14.83, +1.92% vs the prior close of $14.55. Day range $14.09–$14.84, opened at $14.46.
- Volume was 1.44M shares, 0.6x its 50-day average of 2.31M.
- Price is +4.1% vs its 50-day average ($14.24) and +2.6% vs its 200-day average ($14.45).
- 52-week range $11.41–$23.44; today's close sits at 28% of that range, 36.7% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — SGRY rises 2.2% to $14.55, 3 up days in a row
- Closed at $14.55, +2.18% vs the prior close of $14.24. Day range $14.26–$14.77, opened at $14.35.
- Volume was 1.14M shares, 0.5x its 50-day average of 2.31M — lighter than usual.
- Price is +2.1% vs its 50-day average ($14.26) and +0.6% vs its 200-day average ($14.46).
- 52-week range $11.41–$23.44; today's close sits at 26% of that range, 37.9% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — SGRY rises 2.5% to $14.24
- Closed at $14.24, +2.52% vs the prior close of $13.89. Day range $13.68–$14.32, opened at $13.85.
- Volume was 1.21M shares, 0.5x its 50-day average of 2.31M — lighter than usual.
- Price is -0.3% vs its 50-day average ($14.29) and -1.6% vs its 200-day average ($14.46).
- 52-week range $11.41–$23.44; today's close sits at 24% of that range, 39.2% below the 52-week high.
Oct 9, 2026 — SGRY rises 1.8% to $13.89
- Closed at $13.89, +1.83% vs the prior close of $13.64. Day range $13.60–$14.06, opened at $13.69.
- Volume was 929.00K shares, 0.4x its 50-day average of 2.31M — lighter than usual.
- Price is -2.9% vs its 50-day average ($14.31) and -4.0% vs its 200-day average ($14.47).
- 52-week range $11.41–$23.44; today's close sits at 21% of that range, 40.7% below the 52-week high.
Oct 8, 2026 — SGRY dips 0.5% to $13.64
- Closed at $13.64, -0.51% vs the prior close of $13.71. Day range $13.35–$13.71, opened at $13.58.
- Volume was 1.31M shares, 0.6x its 50-day average of 2.34M — lighter than usual.
- Price is -5.0% vs its 50-day average ($14.35) and -5.8% vs its 200-day average ($14.48).
- 52-week range $11.41–$23.44; today's close sits at 19% of that range, 41.8% below the 52-week high.
Oct 7, 2026 — SGRY rises 2.2% to $13.71, 4 up days in a row
- Closed at $13.71, +2.24% vs the prior close of $13.41. Day range $13.34–$13.97, opened at $13.36.
- Volume was 1.69M shares, 0.7x its 50-day average of 2.34M.
- Price is -4.8% vs its 50-day average ($14.41) and -5.4% vs its 200-day average ($14.49).
- 52-week range $11.41–$23.44; today's close sits at 19% of that range, 41.5% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — SGRY rises 0.6% to $13.41, 3 up days in a row
- Closed at $13.41, +0.60% vs the prior close of $13.33. Day range $13.22–$13.57, opened at $13.43.
- Volume was 892.30K shares, 0.4x its 50-day average of 2.36M — lighter than usual.
- Price is -7.2% vs its 50-day average ($14.44) and -7.5% vs its 200-day average ($14.50).
- 52-week range $11.41–$23.44; today's close sits at 17% of that range, 42.8% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — SGRY ends flat (+0.1%) to $13.33
- Closed at $13.33, +0.08% vs the prior close of $13.32. Day range $13.16–$13.50, opened at $13.26.
- Volume was 1.57M shares, 0.7x its 50-day average of 2.41M.
- Price is -7.9% vs its 50-day average ($14.48) and -8.2% vs its 200-day average ($14.51).
- 52-week range $11.41–$23.44; today's close sits at 16% of that range, 43.1% below the 52-week high.
Oct 2, 2026 — SGRY rises 0.7% to $13.32
- Closed at $13.32, +0.68% vs the prior close of $13.23. Day range $13.11–$13.55, opened at $13.35.
- Volume was 1.23M shares, 0.5x its 50-day average of 2.41M — lighter than usual.
- Price is -8.3% vs its 50-day average ($14.53) and -8.3% vs its 200-day average ($14.52).
- 52-week range $11.41–$23.44; today's close sits at 16% of that range, 43.2% below the 52-week high.
SGRY latest news & SEC filings
Every SEC filing by or about SGRY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.01 — Completed an acquisition or sale of assets.
Aug 20, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Deluca Teresa bought 11,250 shares at $14.33 (≈$161.21K) on Aug 18, 2026
- Deluca Teresa bought 11,250 shares at $14.33 (≈$161.21K) on Aug 18, 2026
- Deluca Teresa bought 11,250 shares at $14.33 (≈$161.21K) on Aug 18, 2026
- Deluca Teresa bought 11,250 shares at $14.33 (≈$161.21K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Deluca Teresa bought 10,000 shares at $14.35 (≈$143.50K) on Aug 18, 2026
- Deluca Teresa bought 10,000 shares at $14.35 (≈$143.50K) on Aug 18, 2026
- Deluca Teresa bought 10,000 shares at $14.35 (≈$143.50K) on Aug 18, 2026
- Deluca Teresa bought 10,000 shares at $14.35 (≈$143.50K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$15.00M (prior year -$2.50M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.02) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade SGRY
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 2, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.84% (largest 15.7%).
- Liquidity: about 1.95M shares (≈$28.44M) trade per day on average.
- 52-week position: $14.61 vs a range of $11.41–$23.44 (27% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 17 sales; latest: Teresa Deluca bought 11,250 shares on Aug 18, 2026.
- Latest filings: 8-K Sep 17, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 130.92M shares outstanding (Aug 3, 2026), +2.1% vs a year earlier.
- Listing: Nasdaq · industry: Services-General Medical & Surgical Hospitals, NEC.
SGRY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 14.86 | 14.89 | 14.51 | 14.61 | 966.78K |
| Oct 15, 2026 | 15.05 | 15.34 | 14.61 | 14.77 | 2.37M |
| Oct 14, 2026 | 14.46 | 14.84 | 14.09 | 14.83 | 1.44M |
| Oct 13, 2026 | 14.35 | 14.77 | 14.26 | 14.55 | 1.14M |
| Oct 12, 2026 | 13.85 | 14.32 | 13.68 | 14.24 | 1.21M |
| Oct 9, 2026 | 13.69 | 14.06 | 13.60 | 13.89 | 929.00K |
| Oct 8, 2026 | 13.58 | 13.71 | 13.35 | 13.64 | 1.31M |
| Oct 7, 2026 | 13.36 | 13.97 | 13.34 | 13.71 | 1.69M |
| Oct 6, 2026 | 13.43 | 13.57 | 13.22 | 13.41 | 892.30K |
| Oct 5, 2026 | 13.26 | 13.50 | 13.16 | 13.33 | 1.57M |
| Oct 2, 2026 | 13.35 | 13.55 | 13.11 | 13.32 | 1.23M |
| Oct 1, 2026 | 13.81 | 14.28 | 13.14 | 13.23 | 1.87M |
| Sep 30, 2026 | 14.32 | 14.42 | 13.86 | 13.87 | 1.86M |
| Sep 29, 2026 | 14.65 | 14.77 | 14.25 | 14.41 | 1.42M |
| Sep 28, 2026 | 14.18 | 14.71 | 14.14 | 14.69 | 1.10M |
| Sep 25, 2026 | 14.22 | 14.67 | 14.19 | 14.40 | 1.76M |
| Sep 24, 2026 | 14.38 | 14.52 | 13.98 | 14.20 | 2.03M |
| Sep 23, 2026 | 15.72 | 15.84 | 14.43 | 14.56 | 3.72M |
| Sep 22, 2026 | 13.79 | 15.90 | 13.67 | 15.80 | 8.11M |
| Sep 21, 2026 | 13.41 | 13.74 | 13.09 | 13.66 | 2.31M |
About Surgery Partners
Surgery Partners (SGRY) is listed on the Nasdaq and classified by the SEC under “Services-General Medical & Surgical Hospitals, NEC”. Its business address is in BRENTWOOD, TN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1638833.
SGRY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Clifford G Adlerz | Director | Jun 9, 2026 |
| Teresa Deluca | Director | Aug 20, 2026 |
| Lloyd H Dean | Director | Jun 9, 2026 |
| John A Deane | Director | Jun 9, 2026 |
| Laura L Forese | Director | Jun 9, 2026 |
| Blair E Hendrix | Director | Jul 14, 2026 |
| Brent Turner | Director | Jun 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jennifer Baldock | Chief Admin & Dev Officer | Mar 16, 2026 |
| Marissa Brittenham | Chief Strategy Officer | Mar 16, 2026 |
| Danielle Burkhalter | Chief Human Resources Officer | Mar 16, 2026 |
| David T Doherty | Chief Financial Officer | Mar 16, 2026 |
| Jason Eric Evans | Chief Executive Officer | Mar 16, 2026 |
| Justin Robert Oppenheimer | COO & National Group President | Mar 9, 2026 |
| William Trenton Webb | American Group President | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Teresa Deluca | Buy | 11,250 | $14.33 |
| Aug 18, 2026 | Teresa Deluca | Buy | 11,250 | $14.33 |
| Aug 18, 2026 | Teresa Deluca | Buy | 11,250 | $14.33 |
| Aug 18, 2026 | Teresa Deluca | Buy | 11,250 | $14.33 |
| Aug 18, 2026 | Teresa Deluca | Buy | 10,000 | $14.35 |
| Aug 18, 2026 | Teresa Deluca | Buy | 10,000 | $14.35 |
| Aug 18, 2026 | Teresa Deluca | Buy | 10,000 | $14.35 |
| Aug 18, 2026 | Teresa Deluca | Buy | 10,000 | $14.35 |
| Mar 16, 2026 | Jason Eric Evans | Sale | 20,400 | $12.47 |
| Mar 16, 2026 | Jason Eric Evans | Sale | 20,400 | $12.47 |
| Mar 16, 2026 | Jason Eric Evans | Sale | 20,400 | $12.47 |
| Mar 16, 2026 | Jason Eric Evans | Sale | 20,400 | $12.47 |
| Mar 16, 2026 | David T Doherty | Sale | 8,867 | $12.50 |
| Mar 16, 2026 | David T Doherty | Sale | 8,867 | $12.50 |
| Mar 16, 2026 | David T Doherty | Sale | 8,867 | $12.50 |
SGRY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-77.90M | -0.61 | $274.30M |
| Dec 31, 2024 | — | $-168.10M | -1.33 | $300.10M |
| Dec 31, 2023 | — | $-11.90M | -0.09 | $293.80M |
| Dec 31, 2022 | — | $-54.60M | -0.59 | $158.80M |
| Dec 31, 2021 | — | $-70.90M | -1.12 | $87.10M |
Latest balance sheet: total assets $8.05B, total liabilities $—, cash $216.70M (as of Jun 30, 2026).
SGRY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $15.95 |
| May 5, 2026 | 8-K Item 2.02 (results) | $14.26 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $15.88 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $16.03 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $22.14 |
| May 12, 2025 | 8-K Item 2.02 (results) | $23.26 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $24.00 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $29.57 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-General Medical & Surgical Hospitals, NEC
HCA Healthcare (HCA)Tenet Healthcare (THC)Universal Health Services (UHS)Ardent Health (ARDT)Community Health Systems (CYH)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SGRY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.